In APP/PS1 AD mice, apigenin attenuated deficits in learning and memory, reduced Aβ peptide production, increased the activity of SOD and GPx, and restored ERK/CREB/BDNF-mediated signaling pathway [209]. This evidence concerns the gene APP and Alzheimer disease.